Fischer Chemic Ltd. has approved the acquisition of 100% of the share capital of Time Medical International Ventures, issuance of equity shares on a preferential basis, increase in authorized share capital, alteration of main object clause, increase in borrowing limits, increase in limits for creating charge on assets, increase in limits for making investments/loans/guarantees, change of name of the company, and appointment of a company secretary.